These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8180015

  • 21. Nursing implications in the administration of ifosfamide and mesna.
    Richters JE.
    Oncol Nurs Forum; 1990; 17(2):276. PubMed ID: 2107534
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Severe renal failure following high-dose ifosfamide and mesna.
    Willemse PH, de Jong PE, Elema JD, Mulder NH.
    Cancer Chemother Pharmacol; 1989; 23(5):329-30. PubMed ID: 2495864
    [Abstract] [Full Text] [Related]

  • 24. A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.
    Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Schryber S, Hunt M, Critchlow J, Schnipper L.
    J Clin Oncol; 1991 Feb; 9(2):320-7. PubMed ID: 1846407
    [Abstract] [Full Text] [Related]

  • 25. A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary.
    Crotzer DR, Wolf JK, Gano JB, Gershenson DM, Levenback C.
    Gynecol Oncol; 2007 May; 105(2):399-403. PubMed ID: 17292457
    [Abstract] [Full Text] [Related]

  • 26. The role of ifosfamide in paediatric cancer.
    Advani SH.
    Aust N Z J Med; 1998 Jun; 28(3):410-3. PubMed ID: 9673760
    [Abstract] [Full Text] [Related]

  • 27. Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometry.
    Manz I, Dietrich I, Przybylski M, Niemeyer U, Pohl J, Hilgard P, Brock N.
    Biomed Mass Spectrom; 1985 Sep; 12(9):545-53. PubMed ID: 2932183
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ifosfamide in testicular cancer.
    Loehrer PJ.
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):2-5. PubMed ID: 2159186
    [Abstract] [Full Text] [Related]

  • 30. Preclinical phase II study of ifosfamide in human tumour xenografts in vivo.
    Berger DP, Fiebig HH, Winterhalter BR, Wallbrecher E, Henss H.
    Cancer Chemother Pharmacol; 1990 Apr; 26 Suppl():S7-11. PubMed ID: 2347054
    [Abstract] [Full Text] [Related]

  • 31. Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
    Dorr RT.
    Semin Oncol; 1990 Aug; 17(4 Suppl 7):2-5. PubMed ID: 2116668
    [Abstract] [Full Text] [Related]

  • 32. Ifosfamide in the treatment of soft tissue sarcomas.
    Connelly EF, Budd GT.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
    [Abstract] [Full Text] [Related]

  • 33. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
    Elias A, Ryan L, Sulkes A, Collins J, Aisner J, Antman KH.
    J Clin Oncol; 1989 Sep; 7(9):1208-16. PubMed ID: 2504890
    [Abstract] [Full Text] [Related]

  • 34. The role of ifosfamide in the treatment of testicular and urothelial malignancies.
    Roth BJ.
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):19-27. PubMed ID: 8711497
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Gynecologic Oncology Group experience with ifosfamide.
    Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD.
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):6-10. PubMed ID: 2159188
    [Abstract] [Full Text] [Related]

  • 38. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Evans WK, Stewart D, Logan D, Maroun J, Goss G, Shepherd FA, Latreille J, Warner E, Dahrouge S.
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):51-6. PubMed ID: 1336622
    [Abstract] [Full Text] [Related]

  • 39. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD.
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [Abstract] [Full Text] [Related]

  • 40. A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP, Blessing JA, Homesley HD, Malfetano JH.
    Gynecol Oncol; 1994 Apr; 53(1):24-6. PubMed ID: 8175017
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.